Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Palestinian Resistance sources to Al Mayadeen: Hamas and the factions have officially approved the deal. Trump was notified while he was live on air.
Palestinian Resistance sources to Al Mayadeen: Hamas has agreed to the deal, which will be signed on Thursday in Egypt.
Trump: We are very close to an agreement in the Middle East.
US President Donald Trump: I will most likely go to Egypt.
Russian agency: Russia will conduct a nuclear test if the US does
Al-Nakhalah: We are the rightful owners, and we must fight to retrieve our rights
Al-Nakhalah: The enemy and its allies must know that we can never surrender to their terms and diktats after all the sacrifices made
Al-Nakhalah: The prisoner exchange clause can be completed in the next few days, and thus we will have pulled the [explosion] fuse and removed the enemy's justifications for aggression
Al-Nakhalah: The Resistance has expressed its willingness to negotiate on the basis that there are items that can be dealt with positively, the first of which is the prisoner exchange item
Al-Nakhalah: Trump's plan entails the Palestinian people's declaration of complete surrender to the enemy

Weight-loss drug cuts risk of heart attack, strokes: Novo Nordisk

  • By Al Mayadeen English
  • Source: Agencies
  • 9 Aug 2023 11:10
3 Min Read

This preliminary study implies that this class of weight-loss drugs can impart long-lasting improvements to cardiovascular health.

  • x
  • Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)
    Photo of the former North American headquarters of Novo Nordisk, Inc., in Plainsboro, N.J. taken on April 24, 2008. (AP)

In a statement released on Tuesday that sent the firm's shares leaping to a record high, Danish pharmaceutical giant Novo Nordisk claimed that the obesity medicine Wegovy reduces the risk of heart attacks and strokes by a fifth.

Even though it is preliminary, this is the first study to imply that this class of weight-loss drugs, which has garnered substantial public interest, can impart long-lasting improvements to cardiovascular health.

17,604 overweight or obese adults aged 45 participated in the research, and they were randomly assigned to receive either the injectable medication or a placebo over the course of five years.

Strokes, heart attacks, and cardiovascular deaths all decreased by 20%, according to a statement from Novo Nordisk, though the company did not provide a breakdown for each category.

Read: Mediterranean diet can reduce heart attacks, study finds

It added that it planned to file for regulatory approval to broaden the usage for Wegovy in the US and the EU in 2023. The trial's comprehensive results will be published at a scientific meeting later this year.

Related News

Study finds Ozempic good for the heart, not just weight loss

BMI metric has caused 'historical harm': AMA

On Tuesday, Novo Nordisk's stock price increased by more than 17% at market closing in Copenhagen.

"We are very excited about the results," Martin Holst Lange, the company's executive vice president for development said, adding that the drug "has the potential to change how obesity is regarded and treated".

The results were also welcomed by the medical community.

Even though the trials "still need to be confirmed through careful peer review," they still show "the urgent need for patients living with obesity to be offered this effective and safe drug to prevent future disease," according to Simon Cork, senior lecturer in physiology at Anglia Ruskin University, who did not participate in the research.

According to Naveed Sattar, a professor of metabolic medicine, the University of Glasgow, the results "are exciting as preventing heart attacks and stroke with a drug that also lowers weight is very important for many patients." He also did not take part in the research but has previously consulted for Novo Nordisk.

Wegovy and the diabetes medication Ozempic are both produced by Novo Nordisk, the largest producer of insulin in the world. In May, the company reported a 39 percent increase in first-quarter earnings, helped by sales of its obesity therapies.

The European Medicines Agency, which has its headquarters in Amsterdam, announced in mid-July that it was examining data "on the risk of suicidal thoughts and thoughts of self-harm" with respect to three well-known weight-loss medications: Saxenda, Wegovy, and Ozempic. The last two both contain the active ingredient semaglutide.

Among more than a billion people worldwide suffering from obesity, according to the World Health Organization, there is intense competition among pharmaceutical companies to develop effective therapies.

  • overweight
  • stroke patients
  • Denmark
  • heart failure
  • obesity
  • Novo Nordisk

Most Read

Tucker Carlson speaks at a memorial for Charlie Kirk, Sunday, September 21, 2025, at State Farm Stadium in Glendale, Arizona (AP)

Tucker Carlson: Israeli officers gave orders on Iran inside Pentagon

  • Politics
  • 2 Oct 2025
A Hamas fighter in combat fatigues stands before the ceremony for the handover of Israeli captives to the Red Cross in Nuseirat, central Gaza Strip, Saturday, February 22, 2025 (AP)

Hamas responds to Trump plan, backs Gaza withdrawal, exchange

  • Politics
  • 3 Oct 2025
Mossad’s secret role in Aldo Moro’s 1978 murder revealed

Mossad’s secret role in Aldo Moro’s 1978 murder exposed

  • Politics
  • 5 Oct 2025
The Palestinian resistance and the people of Gaza showed that after combating Israeli aggression for two years, they remain victorious in the face of oppression (Mahdi Rteil/Al Mayadeen English)

Al-Aqsa Flood two years on, a tale of victory

  • Politics
  • 6 Oct 2025

Coverage

All
War on Gaza

Read Next

All
An Israeli armored vehicle moves on a street of a local market during a military raid in the West Bank refugee camp of Balata, Wednesday, October 8, 2025 (AP)
Politics

Israeli settlers kill Palestinian youth near Ramallah amid raids

Russian Foreign Minister Sergey Lavrov speaks during the Moscow format consultations on Afghanistan in Moscow, Russia, Tuesday, Oct. 7, 2025 (AP)
Politics

Iran interested in resuming nuclear talks: Lavrov

International Monetary Fund (IMF) Managing Director Kristalina Georgieva speaks during a news conference at the International Monetary Fund (IMF) headquarters in Washington, April 25, 2025 (AP)
Politics

IMF head flags US budget, Europe Defense spending challenges

Prime Minister of Italy Giorgia Meloni addresses the 80th session of the United Nations General Assembly, Wednesday, Sept. 24, 2025, at UN headquarters (AP)
Politics

Meloni faces ICC complaint over Gaza genocide complicity with Israelis

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS